Trofenciuc, N., Bordejevic, A. D., Tomescu, M. C., Petrescu, L., Crisan, S., Geavlete, O., . . . Pop-Moldovan, A. L. (2020). Toll-like receptor 4 (TLR4) expression is correlated with T2* iron deposition in response to doxorubicin treatment: Cardiotoxicity risk assessment. Sci Rep.
استشهاد بنمط شيكاغوTrofenciuc, Nelu-Mihai, et al. "Toll-like Receptor 4 (TLR4) Expression Is Correlated With T2* Iron Deposition in Response to Doxorubicin Treatment: Cardiotoxicity Risk Assessment." Sci Rep 2020.
MLA استشهادTrofenciuc, Nelu-Mihai, et al. "Toll-like Receptor 4 (TLR4) Expression Is Correlated With T2* Iron Deposition in Response to Doxorubicin Treatment: Cardiotoxicity Risk Assessment." Sci Rep 2020.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.